Published in Diabetes on October 01, 2002
Glucose shortens the life span of C. elegans by downregulating DAF-16/FOXO activity and aquaporin gene expression. Cell Metab (2009) 2.20
Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proc Natl Acad Sci U S A (2003) 1.81
Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci U S A (2007) 1.76
Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci U S A (2005) 1.60
Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc Natl Acad Sci U S A (2004) 1.23
Aquaporin 9 is the major pathway for glycerol uptake by mouse erythrocytes, with implications for malarial virulence. Proc Natl Acad Sci U S A (2007) 1.18
Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice. J Biol Chem (2011) 1.04
The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol (2008) 0.94
Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control. Cell Cycle (2011) 0.92
Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care (2011) 0.91
Aquaporin expression in normal and pathological skeletal muscles: a brief review with focus on AQP4. J Biomed Biotechnol (2010) 0.91
Expression of heterologous aquaporins for functional analysis in Saccharomyces cerevisiae. Curr Genet (2006) 0.87
Altered aquaporin 9 expression and localization in human hepatocellular carcinoma. HPB (Oxford) (2009) 0.85
Aquaporin 9 expression and its localization in normal skeletal myofiber. J Mol Histol (2009) 0.83
Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity. Cardiovasc Diabetol (2013) 0.82
Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease. Int J Obes (Lond) (2013) 0.81
Osteoclast differentiation and function in aquaglyceroporin AQP9-null mice. Biol Cell (2009) 0.81
Sexual Dimorphism of Adipose and Hepatic Aquaglyceroporins in Health and Metabolic Disorders. Front Endocrinol (Lausanne) (2015) 0.81
Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease. PLoS One (2013) 0.81
Expression of aquaporin 9 in rat liver and efferent ducts of the male reproductive system after neonatal diethylstilbestrol exposure. J Histochem Cytochem (2007) 0.80
Physiological role of aquaporin 5 in salivary glands. Pflugers Arch (2015) 0.78
Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice. Sci Rep (2015) 0.78
Deletion of glycerol channel aquaporin-9 (Aqp9) impairs long-term blood glucose control in C57BL/6 leptin receptor-deficient (db/db) obese mice. Physiol Rep (2015) 0.77
Biophysical assessment of human aquaporin-7 as a water and glycerol channel in 3T3-L1 adipocytes. PLoS One (2013) 0.76
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Front Genet (2016) 0.76
Hepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research Trends. Int J Mol Sci (2016) 0.75
Unavailability of liver triacylglycerol increases serum cholesterol concentration induced by dietary cholesterol in exogenously hypercholesterolemic (ExHC) rats. Lipids Health Dis (2014) 0.75
Analysis of aquaporin expression in liver with a focus on hepatocytes. Histochem Cell Biol (2015) 0.75
Effects of visceral adiposity on glycerol pathways in gluconeogenesis. Metabolism (2016) 0.75
Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver. Med Mol Morphol (2013) 0.75
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Suppression of aging in mice by the hormone Klotho. Science (2005) 8.11
Retracted Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science (2004) 7.21
Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes (2007) 6.81
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med (2005) 6.04
Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol (2003) 4.86
Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem (2003) 4.38
Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med (2004) 4.05
Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol (2003) 3.89
Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem (2003) 3.86
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2002) 3.81
Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol (2003) 3.78
Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation (2003) 3.73
Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet (2002) 3.68
Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes (2003) 3.28
Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res (2004) 3.16
Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem (2002) 3.05
Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem (2004) 3.01
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A (2004) 2.85
The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb (2005) 2.77
Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res (2007) 2.66
Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension (2004) 2.65
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation (2004) 2.58
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology (2003) 2.53
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes (2002) 2.49